Ventus Pharmaceuticals Pvt. Ltd. is an ISO 9001:2015 certified pharmaceutical company established in 2009 and engaged in PCD Pharma Franchise, pharmaceutical marketing and healthcare product distribution across India. With over 15 years of industry expertise, the company offers an extensive portfolio of more than 500 DCGI-approved pharmaceutical formulations covering General Medicine, Gynecology, Orthopedics, Critical Care, Neuropsychiatry, Ayurvedic and Nutraceutical products. Ventus Pharmaceuticals continuously expands its product range by introducing innovative molecules to meet evolving market demands while providing comprehensive promotional support, product updates and marketing materials to its franchise partners. Committed to quality, innovation and customer satisfaction, the company has built a strong reputation as a trusted partner for pharmaceutical professionals seeking reliable PCD Pharma Franchise opportunities and quality healthcare products.
| Basic Information | |
|---|---|
| Nature of Business | PCD Pharma Franchise & Pharma Marketing Company |
| Additional Business |
|
| CEO | Mr. Girjesh Kumar Singh |
| Registered Address | SCO No. 8, 2nd Floor, Swastik Vihar, MDC Sector-5, Panchkula – 134019, Haryana, India. |
| Office Address | Plot No. 216, HSIIDC Industrial Estate, Alipur (Barwala), District Panchkula, Haryana, India. |
| Year of Establishment | 2009 |
| Industry | Manufacturing & Marketing of Pharmaceutical Medicines, Nutraceuticals and Ayurvedic Products |
| Total Number of Employees | 20 to 50 People |
| Legal Status of Firm | Private Limited Company |
| Product Portfolio | 500+ DCGI Approved Pharmaceutical Products |
| Molecule Range | 350+ Pharmaceutical Molecules |
| Statutory Profile | |
| GST No. | 06AADCV8537F1Z |
| CIN | U24132CH2011PTC033361 |
| Banker | HDFC Bank |
| Quality Standards | |
| Certifications | ISO 9001:2015 Certified Company & DCGI Approved Product Portfolio |
| Business Strengths |
|
| Packaging, Payment & Shipment Details | |
| Payment Mode |
|
| Shipment Mode |
|
Leave a Reply